Alzheimer's Association Lobbies for Medicare Coverage of Leqembi and Other Drugs

  • 📰 Medscape
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 55%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Alzheimer's association lobbies for medicare coverage of leqembi and other drugs. medtwitter Alzheimer medicare

WASHINGTON, March 16 - The Alzheimer's Association has deployed 1,000 people diagnosed with, or caring for someone with the disease, to meet with all 535 members of Congress across the United States and urge them to press Medicare for early access to a new class of drugs, beginning with lecanemab, that promise to slow the disease.

The Alzheimer's Association and the pharmaceutical industry say the drug companies are not directly involved in the campaign. CMS said its framework includes a broader coverage pathway if the drugs receive standard FDA approval. Leqembi belongs to a new generation of treatments designed to slow advance of the disease by removing sticky clumps of the toxic protein beta amyloid from the brain.

"It was quite a flurry of meetings, one after another, and, to a person, there is not a person who said that they would not sign on to the ask," Garcia told Reuters."There was one day where I think I hit five meetings."

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 386. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Alzheimer's Association lobbies for Medicare coverage of Leqembi and other drugsThe Alzheimer's Association has deployed 1,000 people diagnosed with, or caring for someone with the disease, to meet with all 535 members of Congress across the United States and urge them to press Medicare for early access to a new class of drugs, beginning with lecanemab, that promise to slow the disease. Forcing our premiums to keep rising... Noooooooo! The Medicare premiums will go up again.
Source: Reuters - 🏆 2. / 97 Read more »

Alzheimer's Association expects population with disease to double by 2025The Alzheimer's Association expects the number of people with the disease to double in the next 25 years. yeah its almost like people are getting old 😱
Source: ABC7Chicago - 🏆 284. / 63 Read more »

Alzheimer’s diagnoses expected to reach nearly 13 million by 2050, says new reportA new report published by the Alzheimer’s Association highlights the growing rate of Alzheimer's disease diagnoses, along with the health care shortage and rising costs. WOW!! With all the money being spent on climate change and Ukraine why not fund research for this awful disease Funny how back in the days there weren't so many medical conditions like this.. now they are everywhere and big pharma has a commercial for everything.. its our food and water and because goverment dosent care here we are..
Source: FoxNews - 🏆 9. / 87 Read more »